Digital Creative is a UX and tech agency in Shanghai focused on building digital products and experiences that help businesses grow in China. The agency designs and develops web, WeChat, and mobile apps, including complex digital business systems from consumer touchpoints to powerful backend applications.
Digital Creative is a UX and tech agency based in Shanghai that builds digital products and experiences to help businesses grow in China. Founded in 2014, the agency is headquartered at 3/F, 176 Xietu Dong Lu, Huangpu, Shanghai. The profile positions the studio as a full-service partner for companies working across the Chinese digital ecosystem.
The agency reports fewer than 49 employees, a minimum project budget of $10,000-$25,000, and an average hourly rate of $149. Digital Creative can be reached through its website at digitalcreative.cn and maintains public profiles on LinkedIn and Instagram.
Digital Creative specializes in designing and developing web, WeChat, and mobile apps. Its work covers complex digital business systems that span consumer touchpoints and powerful backend applications, with UI/UX design, web development, and mobile app development listed as its core services.
The agency's listed clients include Ikea, Microsoft, Intel, UBS, and Biogen. The profile does not provide detailed case studies or project descriptions, but the client list shows enterprise-level engagements across multiple sectors.
The DesignRush profile includes company photos and professional social links but no Google reviews or third-party testimonials. The overview text highlights the agency's focus on helping businesses grow in China through locally relevant product design and technology work.
Services
- UI/UX Design
- Web Development
- Mobile App Development
Team Size
Pros
- Specializes in complex digital business systems spanning consumer touchpoints and backend applications.
- Covers web, WeChat, and mobile app design and development from a Shanghai base.
- Founded in 2014 with listed clients including Ikea, Microsoft, Intel, UBS, and Biogen.